Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 50, Issue 49, 2003, Pages 183-187

  Barone, Michele ^a   Ettorre, Giovanni Carlo ^a   Ladisa, Roberta ^a   Schiavariello, Marianna ^a   Santoro, Cosima ^a   Francioso, Giuseppe ^a   Vinciguerra, Vincenzo ^a   Francavilla, Antonio ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Hepatocellular carcinoma; TACE

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; DOXORUBICIN; IODINATED POPPYSEED OIL; MITOMYCIN C;

ABDOMINAL PAIN; ADULT; AGED; ARTERY CATHETERIZATION; ARTICLE; ARTIFICIAL EMBOLISM; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FEVER; HEPATIC ARTERY; HUMAN; JAUNDICE; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETERIZATION; CHEMOEMBOLIZATION, THERAPEUTIC; DOXORUBICIN; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 12244308510     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Gozzetti G, Mazziotti A, Cavallari A, et al: Hepatic resection for tumors in cirrhotic livers. Intern Surg 1987; 72:82-86.
2. Bismuth H, Houssin D, Ornowski J, et al: Liver resections in cirrhotic patients: a western experience. World J Surg 1986; 10:311-317.
3. Bismuth H, Chiche L: Comparison of hepatic resection and transplantation in the treatment of liver cancer. Semin Surg Oncol 1993; 9:341-345.
4. Mazzaferro V, Regalia E, Doci R, et al: Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 1996; 334:693-699.
5. Ranjan D, Johnston TD: Liver transplantation for hepatocellular carcinoma. Hepatogastroenterology 1998; 45:1369-1374.
6. Parkin DM, Stjernsward J, Muir CS: Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ 1984; 62:163-182.
7. Simonetti RG, Camma C, Fiorello F, et al: Hepatocellular carcinoma: a worldwide problem and major risk factor. Dig Dis Sci 1991; 36:962-972.
8. Trevisani F, Caraceni P, Bernardi M, et al: Gross pathologic types of hepatocellular carcinoma in Italian patients: relationship with demographic environmental and clinical factors. Cancer 1993; 72:1557-1563.
9. Farmer DG, Rosove MH, Shaked A, et al. Current treatment modalities for hepatocellular carcinoma. Ann Surg 1994; 219:236-247.
10. Liu CL, Fan ST: Nonresectional therapies from hepatocellular carcinoma. Am J Surg 1997; 173:358-65
11. Simonetti RG, Liberati A, Angiolini C, et al: Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials. Ann Oncol 1997; 8:117-136.
12. Bismuth H, Morino M, Sherlock D, et al: Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992; 163:387-394.
13. Bronowicki JP, Vetter D, Dumas F, et al: Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients. Cancer 1994; 74:16-24.
14. Savastano S, Miotto D, Casarrubea G, et al: Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors. J Clin Gastroenterol 1999; 28:334-340.
15. Stefanini GF, Amorati P, Biselli M, et al: Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience. Cancer 1995; 75:2427-2434.
16. Yang CF, Ho YJ: Transcatheter arterial chemoembolization for hepatocellular carcinoma. Cancer Chemother Pharmacol 1992; 31(Suppl):S86-88.
17. Markovic S, Gadzijev E, Stabuc B, et al: Treatment options in Western hepatocellular carcinoma: a prospective study of 224 patients. J Hepatol 1998; 29:650-659
18. Rose DM, Chapman WC, Brockenbrough AT, et al: Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma. Am J Surg 1999; 177:405-410.
19. Huang YH, Wu JC, Chau GY, et al: Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients. Eur J Gastroenterol Hepatol 1999; 11:315-321.
20. Matsui O, Kadoya M, Yoshikawa J, et al: Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 1993; 188:79-83.
21. Akashi Y, Koreeda C, Enomoto S, et al: Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases. Hepatology 1991; 14:262-268
22. Mondazzi L, Bottelli R, Brambilla G, et al: Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology 1994; 19:1115-1123.
23. Pelletier G, Roche A, Ink O, et al: A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 1990; 11:181-184.
24. Madden MV, Krige JE, Bailey S, et al: Randomized trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma. Gut 1993; 34:1598-1600.
25. Groupe d' Etude et de Traitement du Carcinome Hepatocellulaire: A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995; 332:1256-1261.
26. Pelletier G, Ducreux M, Gay F, et al: Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol 1998; 29:129-134.
27. Bronowicki JP, Boudjema K, Chone L, et al: Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma. J Hepatol 1996;24:293-300.
28. Bismuth H, Samuel D, Engerran L: Treatment of unresectable hepatocellular carcinoma [letter; comment]. N Engl J Med 1995; 333:878.
29. Rees CR: Treatment of unresectable hepatocellular carcinoma [letter; comment]. N Engl J Med 1995; 333:877-878.
30. Yamada R, Sato M, Kawabata M, et al: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148:397-401.
31. Uchida H, Ohishi H, Matsuo N, et al: Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepato-cellular carcinoma. Cardiovasc Intervent Radiol 1990; 13:140-145.
32. Okazaki M, Higashihara H, Shijo H: Chemioembolizazione. In: Livraghi T, Makuuchi M, Buscarini L (Eds.). Epatocarcinoma. Milano: Poletto Editore srl, 1997; pp. 271-288.
33. Ettorre GC, Garriba AP, Francioso G, et al: Chemoembolization of hepatocellular carcinomas: personal experience. Eur Radiol 1992; 2:536-541.
34. Civalleri D, Pellicci R, Decaro G, et al: Palliative chemoembolization of hepatocellular carcinoma with Mitoxantrone, Lipiodol, and Gelofoam. A phase II study. Anti-cancer Res 1996; 16:937-941.
35. Ebara M, Ohto M, Sugiura N, et al: Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients. J Gastroenterol Hepatol 1990; 5:616-626.
36. Francavilla A, Polimeno L, Barone M, et al: Hepatic regeneration and growth factors. J Surg Oncol 1993; 3(Suppl):1-7.
37. Francavilla A, Barone M, Azzarone A, et al: Cell regeneration in pathobiology of liver carcinomas. Ital J Gastroenterol 1991; 23:589-593.
38. Francavilla A, Vujanovich NL, Polimeno L, et al: The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functions. Hepatology 1997; 25:411-415.
39. Francavilla A, Barone M: Cancerogenesi e neoplasie del fegato. In: UNIGASTRO (Eds.). Malattie dell'apparato digerente. Torino: UTET, 1998; pp. 283-291.
40. Vetter D, Wenger JJ, Bergier JM, et al: Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: results of a Western comparative study in 60 patients. Hepatology 1991; 13:427-433.
41. Vogl TJ, Trapp M, Schroeder H, et al: Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a transplantation center. Radiology 2000; 214:349-357.
42. Majno PE, Adam R, Bismuth H, et al: Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226:688-701.
43. Veltri A, Grosso M, Martina MC, et al: Effect of preoperative radiological treatment of hepatocellular before liver transplantation: a retrospective study. Cardiovasc Intervent Radiol 1998; 21:393-398.